EUVIMEDScopri EUVIMED
Randomisierte kontrollierte StudieOpen access

Changes in Plasma Levels of Oxidized Lipoproteins and Lipoprotein Subfractions with Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy and Associations with Common Carotid Artery Intima-Media Thickness: ACTG 5260s

Theodoros Kelesidis, Thuy Tien T Tran, Todd T Brown, Carlee Moser, Heather J Ribaudo, Michael P Dube, Otto O Yang, Grace A McComsey, James H Stein, Judith S Currier

Antiviral Therapy · 2017-02 · 22 (2) · 113-126

DOI: 10.3851/imp3093 ↗

At a glance

Randomisierte kontrollierte Studie in Antiviral Therapy, published online on 2016-02-01. Written by Theodoros Kelesidis and 9 co-authors. Institution: David Geffen School of Medicine at University of California - Los Angeles, Los Angeles, CA, USA. Major MEDLINE topics: Carotid Intima-Media Thickness. Cited 14 times so far (Crossref); 50 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS, NCATS NIH HHS, NHLBI NIH HHS.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

The role of oxidized lipoproteins (high-density [HDLox] and low-density [LDLox]) and total lipoprotein particle (Lp) number and size in HIV-related cardiovascular disease (CVD) is unclear. The goal of this study was to evaluate changes of these biomarkers and their associations with rate of carotid intima media thickness progression over 3 years (ΔCIMT) in chronic HIV infection.

Methods

Prospective study of 234 HIV-infected anti-retroviral treatment-naive participants without CVD who were randomized to receive tenofovir-emtricitabine plus atazanavir/ritonavir, darunavir/ritonavir or raltegravir (RAL) and achieved plasma HIV-1 RNA

Subjects

MeSH terms (MEDLINE)

Carotid Intima-Media ThicknessAdultAnti-HIV AgentsAtazanavir SulfateDarunavirEmtricitabineFemaleHIV InfectionsHIV-1HumansLinear ModelsLipoproteins, HDLLipoproteins, LDLMaleMiddle AgedOxidation-ReductionProspective StudiesRNA, ViralRaltegravir PotassiumRitonavirTenofovir

Substances

Anti-HIV AgentsLipoproteins, HDLLipoproteins, LDLRNA, Viraloxidized low density lipoproteinRaltegravir PotassiumAtazanavir SulfateTenofovirEmtricitabineRitonavir

Authors and institutions

  • David Geffen School of Medicine at University of California - Los Angeles, Los Angeles, CA, USA.
  • Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Keck School of Medicine at the University of Southern California, Los Angeles, CA, USA.
  • Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • University Hospitals Case Medical Center, Cleveland, OH, USA.

Funding

  • NIAID NIH HHS
  • NCATS NIH HHS
  • NHLBI NIH HHS

Cite

APA

Kelesidis, T., Tran, T. T. T., Brown, T. T., Moser, C., Ribaudo, H. J., Dube, M. P., Yang, O. O., McComsey, G. A., Stein, J. H., & Currier, J. S. (2017). Changes in Plasma Levels of Oxidized Lipoproteins and Lipoprotein Subfractions with Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy and Associations with Common Carotid Artery Intima-Media Thickness: ACTG 5260s. Antiviral Therapy, 22(2), 113-126. https://doi.org/10.3851/imp3093

Vancouver

Kelesidis T, Tran TTT, Brown TT, Moser C, Ribaudo HJ, Dube MP, et al. Changes in Plasma Levels of Oxidized Lipoproteins and Lipoprotein Subfractions with Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy and Associations with Common Carotid Artery Intima-Media Thickness: ACTG 5260s. Antiviral Therapy. 2017;22(2):113-126. doi:10.3851/imp3093

BibTeX
@article{Kelesidis2017,
  author = {Kelesidis, Theodoros and Tran, Thuy Tien T and Brown, Todd T and Moser, Carlee and Ribaudo, Heather J and Dube, Michael P and Yang, Otto O and McComsey, Grace A and Stein, James H and Currier, Judith S},
  title = {Changes in Plasma Levels of Oxidized Lipoproteins and Lipoprotein Subfractions with Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy and Associations with Common Carotid Artery Intima-Media Thickness: ACTG 5260s},
  journal = {Antiviral Therapy},
  year = {2017},
  volume = {22},
  number = {2},
  pages = {113--126},
  doi = {10.3851/imp3093}
}
Start for free →